A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer

Clinical trial NCT00356681 · TERMINATED

Trial details

NCT number: NCT00356681
Sponsor: Amgen
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms Breast Tumors Breast Cancer Locally Recurrent and Metastatic Breast Cancer

Start date: 2006-12-01
Primary completion: 2009-02-01
Enrollment: 282

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.